Fluorodeoxyglucose metabolism associated with tau‐amyloid interaction predicts memory decline
Bernard Hanseeuw(Cliniques Universitaires Saint-Luc), Keith A. Johnson(Brigham and Women's Hospital), John S. Bark(Harvard University), Jorge Sepulcre(Harvard University), Rebecca A. Betensky(Harvard University), Danielle M. Cosio(Gordon Center for Medical Imaging), Aaron P. Schultz(Harvard University), Kathryn V. Papp(Brigham and Women's Hospital), Dorene M. Rentz(Brigham and Women's Hospital), Elizabeth C. Mormino(Allen Institute for Brain Science), Molly R. LaPoint, Jasmeer P. Chhatwal(Harvard University), Reisa A. Sperling(Harvard University)
Cited by 141
Related Papers
NIA‐AA Research Framework: Toward a biological definition of Alzheimer's disease
|Alzheimer s & Dementia|2018|10.4k
Toward defining the preclinical stages of Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
|Alzheimer s & Dementia|2011|7.1k
Clinical and Biomarker Changes in Dominantly Inherited Alzheimer's Disease
|New England Journal of Medicine|2012|3.8k
A conceptual framework for research on subjective cognitive decline in preclinical Alzheimer's disease
|Alzheimer s & Dementia|2014|3.1k